oxymetazoline has been researched along with Ptosis, Eyelid in 8 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Administering botulinum toxin for the treatment of blepharospasm in patients A and B yielded the expected results; adding oxymetazoline hydrochloride ophthalmic solution (0." | 8.12 | Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series. ( Song, A; Song, J; Song, M; Sung, J, 2022) |
| "Administering botulinum toxin for the treatment of blepharospasm in patients A and B yielded the expected results; adding oxymetazoline hydrochloride ophthalmic solution (0." | 4.12 | Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series. ( Song, A; Song, J; Song, M; Sung, J, 2022) |
| "Oxymetazoline, 0." | 2.94 | Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials. ( Foster, S; Jaros, M; Kannarr, SR; Korenfeld, MS; Slonim, CB; Smyth-Medina, R; Wirta, DL, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, J | 1 |
| Yang, D | 1 |
| Ugradar, S | 2 |
| Kim, JS | 1 |
| Trost, N | 1 |
| Parunakian, E | 1 |
| Zimmerman, E | 1 |
| Ameli, K | 2 |
| Shoji, MK | 2 |
| Lee, WW | 2 |
| Sung, J | 1 |
| Song, A | 1 |
| Song, M | 1 |
| Song, J | 1 |
| Bernardini, FP | 1 |
| Skippen, B | 1 |
| Croasdell, B | 1 |
| Cerón Bohórquez, JM | 1 |
| Murray, G | 1 |
| Sayed, K | 1 |
| Walker, L | 1 |
| Hartstein, ME | 1 |
| Carruthers, J | 1 |
| Markatia, Z | 1 |
| Bayaraa, M | 1 |
| Clauss, KD | 1 |
| Slonim, CB | 1 |
| Foster, S | 1 |
| Jaros, M | 1 |
| Kannarr, SR | 1 |
| Korenfeld, MS | 1 |
| Smyth-Medina, R | 1 |
| Wirta, DL | 1 |
| Bradley, EA | 1 |
| Bradley, DJ | 1 |
2 trials available for oxymetazoline and Ptosis, Eyelid
| Article | Year |
|---|---|
The effects of topical oxymetazoline on eyelid position, eye redness, and patient-reported eye appearance: A randomized controlled trial.
Topics: Adult; Blepharoptosis; Eyelids; Female; Humans; Male; Middle Aged; Oxymetazoline; Patient Reported O | 2023 |
Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Blepharoptosis; Dose-Response | 2020 |
6 other studies available for oxymetazoline and Ptosis, Eyelid
| Article | Year |
|---|---|
Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline.
Topics: Aged; Blepharoptosis; Eyelids; Female; Humans; Myasthenia Gravis; Oxymetazoline; Visual Fields | 2021 |
Changes to Eye Whiteness and Eyelid/Brow Position With Topical Oxymetazoline in Aesthetic Patients.
Topics: Blepharoptosis; Esthetics; Eyelids; Humans; Oxymetazoline; Prospective Studies | 2022 |
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series.
Topics: Blepharoptosis; Blepharospasm; Botulinum Toxins; Botulinum Toxins, Type A; Female; Humans; Middle Ag | 2022 |
Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
Topics: Blepharoptosis; Botulinum Toxins, Type A; Clostridium botulinum; Humans; Neuromuscular Agents; Oxyme | 2023 |
Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
Topics: Blepharoptosis; Botulinum Toxins, Type A; Clostridium botulinum; Humans; Neuromuscular Agents; Oxyme | 2023 |
Oxymetazoline for Ptosis.
Topics: Blepharoptosis; Humans; Oxymetazoline; Randomized Controlled Trials as Topic; Visual Fields | 2020 |